Matches in Wikidata for { <http://www.wikidata.org/entity/Q58546457> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q58546457 description "article scientifique publié en 2018" @default.
- Q58546457 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q58546457 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58546457 description "scientific article published on 09 August 2018" @default.
- Q58546457 description "wetenschappelijk artikel" @default.
- Q58546457 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q58546457 name "Targeted Therapeutic Drug Monitoring for Direct Oral Anticoagulants: What Is Its Potential Place and Can It Limit Black Swan Events?" @default.
- Q58546457 name "Targeted Therapeutic Drug Monitoring for Direct Oral Anticoagulants: What Is Its Potential Place and Can It Limit Black Swan Events?" @default.
- Q58546457 type Item @default.
- Q58546457 label "Targeted Therapeutic Drug Monitoring for Direct Oral Anticoagulants: What Is Its Potential Place and Can It Limit Black Swan Events?" @default.
- Q58546457 label "Targeted Therapeutic Drug Monitoring for Direct Oral Anticoagulants: What Is Its Potential Place and Can It Limit Black Swan Events?" @default.
- Q58546457 prefLabel "Targeted Therapeutic Drug Monitoring for Direct Oral Anticoagulants: What Is Its Potential Place and Can It Limit Black Swan Events?" @default.
- Q58546457 prefLabel "Targeted Therapeutic Drug Monitoring for Direct Oral Anticoagulants: What Is Its Potential Place and Can It Limit Black Swan Events?" @default.
- Q58546457 P1433 Q58546457-874DEF3B-D28A-4AB1-8731-61CD1817141D @default.
- Q58546457 P1476 Q58546457-31D6B838-0941-413F-A85A-E74930F72DD4 @default.
- Q58546457 P2093 Q58546457-3892BF88-A1A3-4C68-AC20-472D77BD1C21 @default.
- Q58546457 P304 Q58546457-1931D6E2-98DC-4827-AECE-DE5FB39C7D47 @default.
- Q58546457 P31 Q58546457-736cb7bd-c620-4cb8-a804-06ebffcfec68 @default.
- Q58546457 P31 Q58546457-8AD30339-1968-4165-9BD5-A8196A44FEF0 @default.
- Q58546457 P356 Q58546457-B417C2A0-3E3C-4147-886C-A3E34FD0A165 @default.
- Q58546457 P407 Q58546457-767D0566-97B7-47EA-87AE-959C5B59D35E @default.
- Q58546457 P433 Q58546457-B595701E-6533-4674-976F-B66B8E7DEB07 @default.
- Q58546457 P478 Q58546457-C6D793CC-D10E-4ACA-B629-2C75CEB6BF81 @default.
- Q58546457 P577 Q58546457-CE1C64E7-DCFB-4138-9C54-A948F7FE3A11 @default.
- Q58546457 P698 Q58546457-7319D25F-F446-4B1E-8782-3A88BEA2551F @default.
- Q58546457 P921 Q58546457-7D609D2F-9D15-43FD-8C01-BEE9C9DC005E @default.
- Q58546457 P356 J.CJCA.2018.08.006 @default.
- Q58546457 P698 30404744 @default.
- Q58546457 P1433 Q3502278 @default.
- Q58546457 P1476 "Targeted Therapeutic Drug Monitoring for Direct Oral Anticoagulants: What Is Its Potential Place and Can It Limit Black Swan Events?" @default.
- Q58546457 P2093 "D George Wyse" @default.
- Q58546457 P304 "1393-1395" @default.
- Q58546457 P31 Q13442814 @default.
- Q58546457 P31 Q871232 @default.
- Q58546457 P356 "10.1016/J.CJCA.2018.08.006" @default.
- Q58546457 P407 Q1860 @default.
- Q58546457 P433 "11" @default.
- Q58546457 P478 "34" @default.
- Q58546457 P577 "2018-08-09T00:00:00Z" @default.
- Q58546457 P698 "30404744" @default.
- Q58546457 P921 Q63279445 @default.